SANTA CLARA, Calif. & SAN DIEGO–(BUSINESS WIRE)–Affymetrix Inc. (NASDAQ:AFFX) and Reveal Biosciences LLC, an advanced tissue technologies company, today announced a partnership agreement through which Reveal will use Affymetrix ViewRNA® ISH products for tissue samples
SAN DIEGO–(BUSINESS WIRE)–Reveal Biosciences, LLC, a leading preclinical services laboratory for advanced tissue technologies, is pleased to announce the availability of Advanced Cell Diagnostics’ (ACD) RNAscope® in situ hybridization (ISH) technology. With this collaboration, Reveal
Reveal Biosciences is improving global healthcare with a new generation of data powered pathology to characterize and detect disease.
Follow Us
contact
Reveal Biosciences, Inc.
6760 Top Gun St, Suite 110
San Diego, CA 92121
Copyright © 2023 All rights reserved.
Sign up to receive updates on the latest AI-powered pathology breakthroughs, access digital pathology resources, and more.